Company intelligence / Profile preview

Panther Pharmaceuticals

Rockaway, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Panther Pharmaceuticals was a private biopharmaceutical company focused on the development of therapies for bone-related disorders. The company's primary focus was on developing improved formulations and combinations of bisphosphonates, specifically risedronate, for the treatment of osteoporosis and Paget's disease. Panther Pharmaceuticals was acquired by Warner Chilcott in 2008 to strengthen its women's healthcare and bone health portfolio. Following the acquisition, its lead programs were integrated into Warner Chilcott's development pipeline, which was subsequently absorbed by Actavis (now Teva/AbbVie) through further industry consolidation.

Therapeutic areas: EndocrinologyRheumatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Panther Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panther Pharmaceuticals.

Explore the full profile